Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hoffman

Showing results (791-800 of 814) with videos related to

Pageof 82
Sort By:
Cancer|October 25, 2011
Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic diseaseJoseph K Salama, Michael D Hasselle, Steven J Chmura, et al.
Hepatology Communications|September 24, 2021
Detection of Hepatitis B Virus-Host Junction Sequences in Urine of Infected PatientsSelena Y Lin, Yih-Ping Su, Evan R Trauger, et al.
The Journal of Biological Chemistry|February 23, 2024
Analysis of Poly(ethylene terephthalate) degradation kinetics of evolved IsPETase variants using a surface crowding modelEn Ze Linda Zhong-Johnson, Ziyue Dong, Christopher T Canova, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1980
Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agentA W Alberts, J Chen, G Kuron, et al.
Journal of Great Lakes Research|May 24, 2024
Feasibility of implementing an integrated long-term database to advance ecosystem-based management in the Laurentian Great Lakes basinRichard R Budnik, Kenneth T Frank, Lyndsie M Collis, et al.
Gut|June 17, 2010
A randomised placebo-controlled multicentre trial of intravenous semapimod HCl for moderate to severe Crohn's diseaseIris Dotan, Daniel Rachmilewitz, Stefan Schreiber, et al.
Medical Oncology (Northwood, London, England)|August 24, 2010
Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced carcinoma of the esophagus or gastroesophageal junctionNicholas W Choong, Ann M Mauer, Daniel C Haraf, et al.
Neuro-Oncology|October 10, 2022
Neurological applications of belzutifan in von Hippel-Lindau diseaseYue Zhang, Catherine C Nguyen, Nigel T Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2015
Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non-Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III TrialKaren Kelly, Nasser K Altorki, Wilfried E E Eberhardt, et al.
Geroscience|May 10, 2022
Persistent viral RNA shedding of SARS-CoV-2 is associated with delirium incidence and six-month mortality in hospitalized COVID-19 patientsAyush Batra, Jeffrey R Clark, Anthony K Kang, et al.
Pageof 82

Showing results (791-800 of 814) with videos related to

Sort By:
Pageof 82
Cancer|October 25, 2011
Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic diseaseJoseph K Salama, Michael D Hasselle, Steven J Chmura, et al.
Hepatology Communications|September 24, 2021
Detection of Hepatitis B Virus-Host Junction Sequences in Urine of Infected PatientsSelena Y Lin, Yih-Ping Su, Evan R Trauger, et al.
The Journal of Biological Chemistry|February 23, 2024
Analysis of Poly(ethylene terephthalate) degradation kinetics of evolved IsPETase variants using a surface crowding modelEn Ze Linda Zhong-Johnson, Ziyue Dong, Christopher T Canova, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1980
Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agentA W Alberts, J Chen, G Kuron, et al.
Journal of Great Lakes Research|May 24, 2024
Feasibility of implementing an integrated long-term database to advance ecosystem-based management in the Laurentian Great Lakes basinRichard R Budnik, Kenneth T Frank, Lyndsie M Collis, et al.
Gut|June 17, 2010
A randomised placebo-controlled multicentre trial of intravenous semapimod HCl for moderate to severe Crohn's diseaseIris Dotan, Daniel Rachmilewitz, Stefan Schreiber, et al.
Medical Oncology (Northwood, London, England)|August 24, 2010
Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced carcinoma of the esophagus or gastroesophageal junctionNicholas W Choong, Ann M Mauer, Daniel C Haraf, et al.
Neuro-Oncology|October 10, 2022
Neurological applications of belzutifan in von Hippel-Lindau diseaseYue Zhang, Catherine C Nguyen, Nigel T Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2015
Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non-Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III TrialKaren Kelly, Nasser K Altorki, Wilfried E E Eberhardt, et al.
Geroscience|May 10, 2022
Persistent viral RNA shedding of SARS-CoV-2 is associated with delirium incidence and six-month mortality in hospitalized COVID-19 patientsAyush Batra, Jeffrey R Clark, Anthony K Kang, et al.
Pageof 82